Crucial role of donor-derived stromal cells in successful treatment for intractable autoimmune diseases in MRL/lpr mice by BMT via portal vein

Stem Cells

Volumn 19, Issue 3, 2001, Pages 226-235

  Kushida, Taketoshi ^a   Inaba, Muneo ^a   Hisha, Hiroko ^a   Ichioka, Naoya ^a   Esumi, Takashi ^a   Ogawa, Ryokei ^a   Iida, Hirokazu ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone marrow transplantation; MRL lpr mouse; Portal vein; Stromal cells

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; FEMALE; HISTOLOGY; LIVER CELL; MOUSE; NONHUMAN; SPLEEN CELL; STROMA CELL; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALIA;

EID: 0034965088     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.19-3-226     Document Type: Article

References (43)

1. Treatment of murine lupus with monoclonal anti-T cell antibody
2. + T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice
3. Bone marrow transplantation for autoimmune diseases
4. Autoimmune diseases as stem cell disorders: Normal stem cell transplant for their treatment
5. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells
6. Rationale for bone marrow transplantaion in the treatment of autoimmune disease
7. Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation
8. (NZW × BXSB) F1 mouse, a new model of idiopathic thrombocytopenic purpura
9. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation
10. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation
11. Successful bone marrow transplantation by bone grafts in chimeric-resistant combination
12. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bone (stromal cells) from MRL/lpr mice
13. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo
14. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice
15. Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: Possible explanation by portal vein injection
16. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells
17. A strategy for organ allo-grafts without using immunosuppressants or irradiation
18. Acceptace of skin allo-grafts in pigs by portal venous injection of donor bone marrow cells
19. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation
20. Separation of mouse spleen cells by passage through columns of Sephadex G-10
21. Conditions controlling the proliferation of hemopoietic stem cells in vitro
22. Monoclonal antibodies against a preadipose cell line (MC3T3-G2/PA6) which can support hemopoiesis
23. Granulocyte-macrophage colony-stimulating factor and vasculitis
24. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor
25. Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis
26. Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapy
27. Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte-macrophage colony-stimulating factor for Felty's syndrome
28. Vascular cell adhesion molecule-l expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells
29. Roles for integrin very late activation antigen-4 in stroma-dependent erythropoiesis
30. Vascular cell adhesion molecule 1-positive reticular cells express interleukin-7 and stem cell factor in the bone marrow
31. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells
32. Rheumatoid-susceptible alleles of HLA-DRB1 are genetically recessive to nonsusceptible alleles in the progression of bone destruction in the wrists and fingers of patients with RA
33. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome
34. HLA-DRB1*04 subtypes are associated with increased inflammatory activity in early rheumatoid arthritis
35. Bone marrow transplantation in patients with gold-induced marrow aplasia
36. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anemia
37. Apparent cure of rheumatoid arthritis by bone marrow transplantation
38. Clearance of severe psoriasis after allogeneic bone marrow transplantation
39. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukemia
40. Immune ablation followed by allogeneic or autologous bone marrow transplantation: A new treatment for severe autoimmune diseases?
41. Role of hematopoietic stem cell transplantation for autoimmune diseases
42. Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation
43. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation